SARS-CoV2
[대역어] 사스 코로나바이러스 2
[용어속성] Virus
[용어속성] Virus
Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection
SARS-CoV-2 감염의 임상 결과가 좋지 않은 입학 어소시에이트의 낮은 아연 수치
Observational Study
[키워드] acute respiratory syndrome
Admission
antiviral action
Associate
Biomarker
cell line
Chronic diseases
clinical
clinical outcomes
concentrations
coronavirus
correlated
correlation
COVID-19
COVID-19 disease
COVID-19 patient
COVID-19 severity
deficiency
determine
favor
immune responses
Impact
in vitro result
increased risk
individual
Infection
influence
Level
Mortality
Observational cohort study
outcome
outcomes
Poor
progression
Prophylaxis
randomized clinical trial
Replication
risk
risk factor
SARS-CoV-2
SARS-CoV-2 infected cells
SARS-CoV2
serum
severe coronavirus disease
stability
SZC
Treatment
two group
Vero E6
viruses
Zinc
zinc supplementation
[DOI] 10.3390/nu13020562 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.3390/nu13020562 PMC 바로가기 [Article Type] Observational Study
Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics
Debate
[키워드] Algorithm
anti-cytokine treatments
approach
Aspirin
children
clinician
combined use
Corticosteroids
country
COVID-19 cases
diagnose
diagnostic
disease
Epidemic
Evidence
Final
group
Guidance
help
High-dose
Immunoglobulin
Inflammatory
Italian
Italy
management
methodology
MIS-C
organ
patients
pediatrics
physician
SARS-CoV2
severity
Society
syndrome
systemic inflammation
the disease
the SARS-CoV-2
Therapeutic approach
treat
Treatment
with COVID-19
[DOI] 10.1186/s13052-021-00980-2 PMC 바로가기 [Article Type] Debate
[DOI] 10.1186/s13052-021-00980-2 PMC 바로가기 [Article Type] Debate
Rapid community point-of-care testing for COVID-19 (RAPTOR-C19): protocol for a platform diagnostic study
Protocol
[키워드] 95% confidence interval
Accuracy
antibody test results
Antibody testing
asked
baseline
blood sample
calculated
Care
chain
children
clinical care
Community
community testing
contributing to
COVID-19
death
demographics
diagnostic
diagnostic tests
Effects
Electronic health record
eligible
estimates
evaluated
feasible
Health
hospitalisation
household contacts
household transmission
Impact
individual
Infection
ISRCTN
Laboratory
Negative predictive value
outcome
outcomes
participant
Patient
patient reported
performed
PHE
platform
POCT
point-of-care
point-of-care test
point-of-care tests
positive
Prevalence
primary care
protocol
public health
Public Health England
Rapid
reaction
recruited
reducing
reference standard
RT-PCR
SARS-CoV-2 antibody testing
SARS-CoV2
SARS-CoV2 infection
specificity
supplementary material
Surveillance
Swab
symptomatic infection
Symptoms
Testing
transcriptase
Transmission dynamics
[DOI] 10.1186/s41512-021-00093-8 PMC 바로가기 [Article Type] Protocol
[DOI] 10.1186/s41512-021-00093-8 PMC 바로가기 [Article Type] Protocol
Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach
고 처리량 컴퓨터 스크리닝 및 구조 역학 접근을 통한 SARS-COV2의 NSP15에 대한 약물 설계
Article
[키워드] (lopinavir
(ritonavir)
addition
approach
best
binding
binding affinity
butanamide
complement
Compound
computational analysis
contribute
COVID-19
Critical
dataset
dihydrofuran-2(3H)-one
drug
drug candidate
effective
endonuclease
ethyl
explicit
Favipiravir
feature
generate
High Throughput Screening
host immune system
identify
Interference
lead
Lopinavir
molecular dynamics
molecular dynamics simulations
Nsp15
oseltamivir
outbreak
pandemic
pharmacophore
potential therapeutic target
Protein
pyrazine
Replication
Ritonavir
rule
SARS-CoV2
screened
selected
selective
small molecule
therapeutic
training set
Treatment
unique
virulence
was selected
[DOI] 10.1016/j.ejphar.2020.173779 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ejphar.2020.173779 PMC 바로가기 [Article Type] Article
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial
COVID19에 감염된 종양-혈액학적 환자에서 호흡 부전 진행을 예방하기 위한 바리시티닙의 효능을 평가하기 위한 I/II상 임상 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
AAK1
absence
activator
Acute respiratory failure
Administered
administration
Adverse
adverse events
affected
alkaline phosphatase
All participants
allergy
Alpha
alpha error
angina pectoris
Antibiotics
appearance
ARDS
Arm
assigned
AST/ALT
Baricitinib
baseline
beta error
Bilirubin
Blinding
Blood
Breastfeeding
can be used
candidate
Candidates
capture
Cardiac arrhythmia
carried
change
clearance
clinical
clinical condition
clinical suspicion
clinical trials
Coagulation
Cohort
Common Terminology Criteria
Comorbidity
Complete
completion
Compliance
congestive heart failure
control arm
Controlled trial
corticoid
Corticosteroids
COVID19
creatinine
creatinine clearance
CRP
D-dimer
Day
Deep venous thrombosis
description
Deterioration
Dexamethasone
dimer
discharge
discretion
disease
dissemination
diverticulitis
dose
dropout rate
Duration of therapy
ECMO
Efficacy
electronic case report form
element
eligibility criteria
Enrollment
evaluate
exclusion criteria
expected
experimental arm
extracorporeal membrane oxygenation
febrile neutropenia
ferritin
followed by
form
fraction
Gas exchange
greater
HBV
HCV
hemodynamic instability
High-flow nasal cannula
HIV
HIV infection
ICU
immobilization
immunological
impossibility
incidence
include
indication
Infection
infection with SARS-CoV-2
Inflammatory response
interfere
interferon
Interim
interim analysis
interleukin
interleukin 6
interstitial pneumonia
Intervention
intestinal perforation
Invasive mechanical ventilation
investigational agent
investigator
jak inhibitors
Jak-STAT
Laboratory
laboratory parameter
Laboratory parameters
LDH
less
limit
limits
management
mechanical ventilation
medical history
Medicine
meet
Methylprednisolone
Mild ARDS
Mortality
multi organ failure
nasal
nasal cannula
need for oxygen
neutropenia
neutrophil
Neutrophils
Non-invasive
number
objective
on mechanical ventilation
oncological patients
onset of symptom
open
open label
oral medication
organ dysfunction
Organ failure
outcome
oxygen
oxygen support
PaFi
participant
Participants
Participation
pathogen
Pathogens
pathway
Patient
patients
performance status
performed
phase
Phase 1
Phase 2
Phase I
phosphatase
platform
Pneumonia
poor prognosis
positive
Prednisone
pregnancy test
pregnant
prejudice
Prevent
progression
Prophylaxis
Protein
protein kinase
protocol
Psychiatric
psychiatric illness
Pulmonary embolism
radiological
randomisation
randomised
randomised controlled trial
randomization
Randomized
Randomized controlled trial
receive
receptor
recruitment
REDCap
REDcap platform
reduce
reduced
Remdesivir
removal
report
reported
required
respiratory
Respiratory failure
Respiratory function
respiratory insufficiency
respiratory tract
Sample size
SARS-CoV-2
SARS-CoV2
SARS-CoV2 infection
Secondary objectives
Sepsis
severe adverse event
severe adverse events
severe pneumonia
severe respiratory failure
Spain
Spanish
Standard of care
STAT
status
study enrollment
Study protocol
supplemental oxygen requirement
supplemental oxygen requirements
supplementary material
Support
surgical
surgical intervention
Symptom
symptomatic
Tablet
Therapies
therapy
thromboembolic disease
thrombosis
Tocilizumab
total bilirubin
Toxicity
Transcription
transducer
Treatment
treatment period
Trial
unstable angina
use of corticosteroid
Venous thrombosis
Version
viral endocytosis
website
Withdrawal
worsening
[DOI] 10.1186/s13063-021-05072-4 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05072-4 PMC 바로가기 [Article Type] Letter
Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review
Review
[키워드] bioinformatics
biosafety
caused
China
consequence
coronavirus
CoV
COVID-19
COVID-19 pandemic
death
determine
develop
dissemination
Epidemics
Evolution
French
furin
Gain of function
genome analysis
Infection
inferences
Intensive
Interaction
involved
knowledge
Laboratory
mechanism
molecular mechanism
pandemic
Phylogenetic
Phylogeny
Prevent
Proteins
question
responsible
SARS-CoV-2
SARS-CoV2
Sequence analysis
Spike protein
supplementary material
therapeutic
tracing
translation
understanding
Vaccine
Virology
virus
zoonoses
zoonosis
zoonotic
[DOI] 10.1007/s10311-020-01151-1 PMC 바로가기 [Article Type] Review
[DOI] 10.1007/s10311-020-01151-1 PMC 바로가기 [Article Type] Review
Clinical Characteristics and Outcome of Patients With Severe COVID-19 Pneumonia at a Public Sector Hospital in Karachi, Pakistan
Anesthesiology
[키워드] Absolute lymphocyte count
accounted
Acute kidney injury
acute respiratory distress
acute respiratory syndrome
Administered
Admission
age
ARDS
average
Benazir Bhutto
C-reactive protein
cardiac complication
clinical
Clinical characteristics
co-morbidities
co-morbidity
comorbid conditions
complications
conducted
confirmed case
coronavirus
COVID
COVID-19
Critical
CRP
CRS
Cytokine release syndrome
death
demographics
develop
disease
Factor
Fever
Final
hospital
hypertension
intensive care unit
Karachi
lack
LDH
leukocyte
males
mechanical ventilation
median
moderate
Mortality
MOST
neutrophil lymphocyte ratio
NIV
NLR
non-invasive ventilation
Non-survivors
Odds ratio
Older age
on mechanical ventilation
outcome
Pakistan
parameter
Patient
patients
patients died
patients with COVID-19
PCR
peaked
Platelet
Pneumonia
polymerase chain
positive
predominant
public sector
reported
SARS-CoV2
Sepsis
Severe COVID-19 pneumonia
Shortness of breath
statistically significant
Steroids
survival analysis
Survivors
Symptom
syndrome
the median
Tocilizumab
was done
[DOI] 10.7759/cureus.13107 PMC 바로가기 [Article Type] Anesthesiology
[DOI] 10.7759/cureus.13107 PMC 바로가기 [Article Type] Anesthesiology
Mimickers of novel coronavirus disease 2019 (COVID-19) on chest CT: spectrum of CT and clinical features
Educational Review
[키워드] acute respiratory syndrome
caused
Chest
Chest CT
clinical condition
clinical feature
Computed tomography
condition
contagious
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
Diagnosis
diagnostic
differential diagnosis
disease
feature
management
morbidity and mortality
novel coronavirus disease
outcome
physician
Prevent
Pulmonary infection
radiologist
RT-PCR
SARS-CoV-2
SARS-CoV2
sensitivity
specificity
Spread
variety
while
Wuhan, China
[DOI] 10.1186/s13244-020-00956-6 PMC 바로가기 [Article Type] Educational Review
[DOI] 10.1186/s13244-020-00956-6 PMC 바로가기 [Article Type] Educational Review